Attention deficit hyperactivity disorder and Injection site extravasation
Summary:
Injection site extravasation is found among people with Attention deficit hyperactivity disorder, especially for people who are male, 10-19 old.
The study analyzes which people have Injection site extravasation with Attention deficit hyperactivity disorder. It is created by eHealthMe based on reports of 24 people who have Attention deficit hyperactivity disorder from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Attention deficit hyperactivity disorder?
Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness) is found to be associated with 610 drugs and 1,393 conditions by eHealthMe. Check the latest studies of Attention deficit hyperactivity disorder.
What is Injection site extravasation?
Injection site extravasation (flow of (blood or lymph) from injection site) is found to be associated with 555 drugs and 727 conditions by eHealthMe. Check the latest studies of Injection site extravasation.
24 people who have Attention Deficit Hyperactivity Disorder and Injection Site Extravasation are studied.

Gender of people who have Attention Deficit Hyperactivity Disorder and experienced Injection Site Extravasation *:
- female: 47.37 %
- male: 52.63 %
Age of people who have Attention Deficit Hyperactivity Disorder and experienced Injection Site Extravasation *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 38.89 %
- 20-29: 0.0 %
- 30-39: 27.78 %
- 40-49: 11.11 %
- 50-59: 5.5600000000000005 %
- 60+: 16.67 %
Common co-existing conditions for these people *:
- Ankylosing Spondylitis (type of arthritis affecting the spine): 9 people, 37.50%
- Hypersensitivity: 6 people, 25.00%
- Growth Hormone Deficiency: 5 people, 20.83%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 16.67%
- Oppositional Defiant Disorder (a childhood disorder described by the diagnostic and statistical manual of mental disorders): 4 people, 16.67%
- Asthma: 3 people, 12.50%
- Depression: 3 people, 12.50%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 12.50%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 12.50%
- Muscle Spasms (muscle contraction): 2 people, 8.33%
Common drugs taken by these people *:
- Strattera: 10 people, 41.67%
- Pantoprazole: 9 people, 37.50%
- Naprosyn: 9 people, 37.50%
- Humira: 8 people, 33.33%
- Abilify: 5 people, 20.83%
- Adderall: 5 people, 20.83%
- Genotropin: 5 people, 20.83%
- Inflectra: 5 people, 20.83%
- Celebrex: 3 people, 12.50%
- Erelzi: 3 people, 12.50%
Common symptoms for these people *:
- Fatigue (feeling of tiredness): 10 people, 41.67%
- Weight Decreased: 10 people, 41.67%
- Nausea (feeling of having an urge to vomit): 10 people, 41.67%
- Wound Haemorrhage (bleeding wound): 9 people, 37.50%
- Rashes (redness): 9 people, 37.50%
- Blood Pressure Fluctuation: 9 people, 37.50%
- Dry Skin: 9 people, 37.50%
- Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 9 people, 37.50%
- Itching: 9 people, 37.50%
- Abdominal Pain: 9 people, 37.50%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Injection site extravasation?
- Check whether Injection site extravasation is associated with a drug or a conditionRelated publications that referenced our studies
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
Related studies:
Treatments, associated drugs and conditions:
- Attention deficit hyperactivity disorder (120,336 reports)
- Injection site extravasation (14,458 reports)
All the drugs that are associated with Injection site extravasation:
- Injection site extravasation (555 drugs)
All the conditions that are associated with Injection site extravasation:
- Injection site extravasation (727 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Injection site extravasation and Attention deficit hyperactivity disorder, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Eskalith cause Weight Decreased? - 49 seconds ago
- Drug interactions of M.V.I. and Simcor - a minute ago
- Drug interactions of Truvada and Prevacid 24 Hr - a minute ago
- Drug interactions of Cozaar and Tramadol - 2 minutes ago
- Could Lantus cause Renal Artery Stenosis? - 3 minutes ago
- Taztia Xt vs. Isoptin Sr, side effect and effectiveness comparison - 3 minutes ago
- Could Metoclopramide Hydrochloride cause Diabetic Ketoacidosis? - 4 minutes ago
- Drug interactions of Opzelura and Amlodipine - 4 minutes ago
- Could Geodon cause Muscle Spasms? - 4 minutes ago
- Could Avastin cause Muscle Aches? - 4 minutes ago